<LCTL_TEXT lang="rus">
<DOC grammar="none" id="L0C04D4EZ" lang="rus" raw_text_char_length="2501" raw_text_md5="9420687c4e5da5225f7cd71b8719f64c" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="81" id="segment-0" start_char="1">
<ORIGINAL_TEXT>В США одобрили лекарство против COVID-19, которое защищает от осложнений и смерти</ORIGINAL_TEXT>
<TOKEN end_char="1" id="token-0-0" morph="none" pos="word" start_char="1">В</TOKEN>
<TOKEN end_char="5" id="token-0-1" morph="none" pos="word" start_char="3">США</TOKEN>
<TOKEN end_char="14" id="token-0-2" morph="none" pos="word" start_char="7">одобрили</TOKEN>
<TOKEN end_char="24" id="token-0-3" morph="none" pos="word" start_char="16">лекарство</TOKEN>
<TOKEN end_char="31" id="token-0-4" morph="none" pos="word" start_char="26">против</TOKEN>
<TOKEN end_char="40" id="token-0-5" morph="none" pos="unknown" start_char="33">COVID-19</TOKEN>
<TOKEN end_char="41" id="token-0-6" morph="none" pos="punct" start_char="41">,</TOKEN>
<TOKEN end_char="49" id="token-0-7" morph="none" pos="word" start_char="43">которое</TOKEN>
<TOKEN end_char="58" id="token-0-8" morph="none" pos="word" start_char="51">защищает</TOKEN>
<TOKEN end_char="61" id="token-0-9" morph="none" pos="word" start_char="60">от</TOKEN>
<TOKEN end_char="72" id="token-0-10" morph="none" pos="word" start_char="63">осложнений</TOKEN>
<TOKEN end_char="74" id="token-0-11" morph="none" pos="word" start_char="74">и</TOKEN>
<TOKEN end_char="81" id="token-0-12" morph="none" pos="word" start_char="76">смерти</TOKEN>
<TRANSLATED_TEXT>The US has approved a drug against COVID-19, which protects against complications and death</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="256" id="segment-1" start_char="86">
<ORIGINAL_TEXT>Управление по санитарному надзору за качеством пищевых продуктов и медикаментов США (FDA) одобрило экстренное использование лекарств против COVID-19 Sotrovimab (VIR-7831).</ORIGINAL_TEXT>
<TOKEN end_char="95" id="token-1-0" morph="none" pos="word" start_char="86">Управление</TOKEN>
<TOKEN end_char="98" id="token-1-1" morph="none" pos="word" start_char="97">по</TOKEN>
<TOKEN end_char="110" id="token-1-2" morph="none" pos="word" start_char="100">санитарному</TOKEN>
<TOKEN end_char="118" id="token-1-3" morph="none" pos="word" start_char="112">надзору</TOKEN>
<TOKEN end_char="121" id="token-1-4" morph="none" pos="word" start_char="120">за</TOKEN>
<TOKEN end_char="131" id="token-1-5" morph="none" pos="word" start_char="123">качеством</TOKEN>
<TOKEN end_char="139" id="token-1-6" morph="none" pos="word" start_char="133">пищевых</TOKEN>
<TOKEN end_char="149" id="token-1-7" morph="none" pos="word" start_char="141">продуктов</TOKEN>
<TOKEN end_char="151" id="token-1-8" morph="none" pos="word" start_char="151">и</TOKEN>
<TOKEN end_char="164" id="token-1-9" morph="none" pos="word" start_char="153">медикаментов</TOKEN>
<TOKEN end_char="168" id="token-1-10" morph="none" pos="word" start_char="166">США</TOKEN>
<TOKEN end_char="170" id="token-1-11" morph="none" pos="punct" start_char="170">(</TOKEN>
<TOKEN end_char="173" id="token-1-12" morph="none" pos="word" start_char="171">FDA</TOKEN>
<TOKEN end_char="174" id="token-1-13" morph="none" pos="punct" start_char="174">)</TOKEN>
<TOKEN end_char="183" id="token-1-14" morph="none" pos="word" start_char="176">одобрило</TOKEN>
<TOKEN end_char="194" id="token-1-15" morph="none" pos="word" start_char="185">экстренное</TOKEN>
<TOKEN end_char="208" id="token-1-16" morph="none" pos="word" start_char="196">использование</TOKEN>
<TOKEN end_char="217" id="token-1-17" morph="none" pos="word" start_char="210">лекарств</TOKEN>
<TOKEN end_char="224" id="token-1-18" morph="none" pos="word" start_char="219">против</TOKEN>
<TOKEN end_char="233" id="token-1-19" morph="none" pos="unknown" start_char="226">COVID-19</TOKEN>
<TOKEN end_char="244" id="token-1-20" morph="none" pos="word" start_char="235">Sotrovimab</TOKEN>
<TOKEN end_char="246" id="token-1-21" morph="none" pos="punct" start_char="246">(</TOKEN>
<TOKEN end_char="254" id="token-1-22" morph="none" pos="unknown" start_char="247">VIR-7831</TOKEN>
<TOKEN end_char="256" id="token-1-23" morph="none" pos="punct" start_char="255">).</TOKEN>
<TRANSLATED_TEXT>The U.S. Food and Drug Administration (FDA) has approved emergency use of drugs against COVID-19 Sotrovimab (VIR-7831).</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="356" id="segment-2" start_char="258">
<ORIGINAL_TEXT>Их разработала британская компания GSK совместно со своим американским партнером Vir Biotechnology.</ORIGINAL_TEXT>
<TOKEN end_char="259" id="token-2-0" morph="none" pos="word" start_char="258">Их</TOKEN>
<TOKEN end_char="271" id="token-2-1" morph="none" pos="word" start_char="261">разработала</TOKEN>
<TOKEN end_char="282" id="token-2-2" morph="none" pos="word" start_char="273">британская</TOKEN>
<TOKEN end_char="291" id="token-2-3" morph="none" pos="word" start_char="284">компания</TOKEN>
<TOKEN end_char="295" id="token-2-4" morph="none" pos="word" start_char="293">GSK</TOKEN>
<TOKEN end_char="305" id="token-2-5" morph="none" pos="word" start_char="297">совместно</TOKEN>
<TOKEN end_char="308" id="token-2-6" morph="none" pos="word" start_char="307">со</TOKEN>
<TOKEN end_char="314" id="token-2-7" morph="none" pos="word" start_char="310">своим</TOKEN>
<TOKEN end_char="327" id="token-2-8" morph="none" pos="word" start_char="316">американским</TOKEN>
<TOKEN end_char="337" id="token-2-9" morph="none" pos="word" start_char="329">партнером</TOKEN>
<TOKEN end_char="341" id="token-2-10" morph="none" pos="word" start_char="339">Vir</TOKEN>
<TOKEN end_char="355" id="token-2-11" morph="none" pos="word" start_char="343">Biotechnology</TOKEN>
<TOKEN end_char="356" id="token-2-12" morph="none" pos="punct" start_char="356">.</TOKEN>
<TRANSLATED_TEXT>They were developed by the British company GSK together with its American partner Vir Biotechnology.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="371" id="segment-3" start_char="359">
<ORIGINAL_TEXT>Источник: FDA</ORIGINAL_TEXT>
<TOKEN end_char="366" id="token-3-0" morph="none" pos="word" start_char="359">Источник</TOKEN>
<TOKEN end_char="367" id="token-3-1" morph="none" pos="punct" start_char="367">:</TOKEN>
<TOKEN end_char="371" id="token-3-2" morph="none" pos="word" start_char="369">FDA</TOKEN>
<TRANSLATED_TEXT>Source: FDA</TRANSLATED_TEXT><DETECTED_LANGUAGE>mk</DETECTED_LANGUAGE></SEG>
<SEG end_char="457" id="segment-4" start_char="374">
<ORIGINAL_TEXT>Препарат подходит только для лечения легкой и средней формы коронавируса SARS-CoV-2.</ORIGINAL_TEXT>
<TOKEN end_char="381" id="token-4-0" morph="none" pos="word" start_char="374">Препарат</TOKEN>
<TOKEN end_char="390" id="token-4-1" morph="none" pos="word" start_char="383">подходит</TOKEN>
<TOKEN end_char="397" id="token-4-2" morph="none" pos="word" start_char="392">только</TOKEN>
<TOKEN end_char="401" id="token-4-3" morph="none" pos="word" start_char="399">для</TOKEN>
<TOKEN end_char="409" id="token-4-4" morph="none" pos="word" start_char="403">лечения</TOKEN>
<TOKEN end_char="416" id="token-4-5" morph="none" pos="word" start_char="411">легкой</TOKEN>
<TOKEN end_char="418" id="token-4-6" morph="none" pos="word" start_char="418">и</TOKEN>
<TOKEN end_char="426" id="token-4-7" morph="none" pos="word" start_char="420">средней</TOKEN>
<TOKEN end_char="432" id="token-4-8" morph="none" pos="word" start_char="428">формы</TOKEN>
<TOKEN end_char="445" id="token-4-9" morph="none" pos="word" start_char="434">коронавируса</TOKEN>
<TOKEN end_char="456" id="token-4-10" morph="none" pos="unknown" start_char="447">SARS-CoV-2</TOKEN>
<TOKEN end_char="457" id="token-4-11" morph="none" pos="punct" start_char="457">.</TOKEN>
<TRANSLATED_TEXT>It is only suitable for the treatment of mild and medium form of SARS-CoV-2 cor.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="575" id="segment-5" start_char="459">
<ORIGINAL_TEXT>То есть он не предназначен для людей с тяжелым течением болезни или для тех, которые нуждаются в кислородной терапии.</ORIGINAL_TEXT>
<TOKEN end_char="460" id="token-5-0" morph="none" pos="word" start_char="459">То</TOKEN>
<TOKEN end_char="465" id="token-5-1" morph="none" pos="word" start_char="462">есть</TOKEN>
<TOKEN end_char="468" id="token-5-2" morph="none" pos="word" start_char="467">он</TOKEN>
<TOKEN end_char="471" id="token-5-3" morph="none" pos="word" start_char="470">не</TOKEN>
<TOKEN end_char="484" id="token-5-4" morph="none" pos="word" start_char="473">предназначен</TOKEN>
<TOKEN end_char="488" id="token-5-5" morph="none" pos="word" start_char="486">для</TOKEN>
<TOKEN end_char="494" id="token-5-6" morph="none" pos="word" start_char="490">людей</TOKEN>
<TOKEN end_char="496" id="token-5-7" morph="none" pos="word" start_char="496">с</TOKEN>
<TOKEN end_char="504" id="token-5-8" morph="none" pos="word" start_char="498">тяжелым</TOKEN>
<TOKEN end_char="513" id="token-5-9" morph="none" pos="word" start_char="506">течением</TOKEN>
<TOKEN end_char="521" id="token-5-10" morph="none" pos="word" start_char="515">болезни</TOKEN>
<TOKEN end_char="525" id="token-5-11" morph="none" pos="word" start_char="523">или</TOKEN>
<TOKEN end_char="529" id="token-5-12" morph="none" pos="word" start_char="527">для</TOKEN>
<TOKEN end_char="533" id="token-5-13" morph="none" pos="word" start_char="531">тех</TOKEN>
<TOKEN end_char="534" id="token-5-14" morph="none" pos="punct" start_char="534">,</TOKEN>
<TOKEN end_char="542" id="token-5-15" morph="none" pos="word" start_char="536">которые</TOKEN>
<TOKEN end_char="552" id="token-5-16" morph="none" pos="word" start_char="544">нуждаются</TOKEN>
<TOKEN end_char="554" id="token-5-17" morph="none" pos="word" start_char="554">в</TOKEN>
<TOKEN end_char="566" id="token-5-18" morph="none" pos="word" start_char="556">кислородной</TOKEN>
<TOKEN end_char="574" id="token-5-19" morph="none" pos="word" start_char="568">терапии</TOKEN>
<TOKEN end_char="575" id="token-5-20" morph="none" pos="punct" start_char="575">.</TOKEN>
<TRANSLATED_TEXT>That is, it is not intended for people with severe disease or those in need of oxygen therapy.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="691" id="segment-6" start_char="578">
<ORIGINAL_TEXT>Сотровимабом будут лечить людей, имеющих высокий риск прогрессирования COVID-19 до тяжелой формы и госпитализации.</ORIGINAL_TEXT>
<TOKEN end_char="589" id="token-6-0" morph="none" pos="word" start_char="578">Сотровимабом</TOKEN>
<TOKEN end_char="595" id="token-6-1" morph="none" pos="word" start_char="591">будут</TOKEN>
<TOKEN end_char="602" id="token-6-2" morph="none" pos="word" start_char="597">лечить</TOKEN>
<TOKEN end_char="608" id="token-6-3" morph="none" pos="word" start_char="604">людей</TOKEN>
<TOKEN end_char="609" id="token-6-4" morph="none" pos="punct" start_char="609">,</TOKEN>
<TOKEN end_char="617" id="token-6-5" morph="none" pos="word" start_char="611">имеющих</TOKEN>
<TOKEN end_char="625" id="token-6-6" morph="none" pos="word" start_char="619">высокий</TOKEN>
<TOKEN end_char="630" id="token-6-7" morph="none" pos="word" start_char="627">риск</TOKEN>
<TOKEN end_char="647" id="token-6-8" morph="none" pos="word" start_char="632">прогрессирования</TOKEN>
<TOKEN end_char="656" id="token-6-9" morph="none" pos="unknown" start_char="649">COVID-19</TOKEN>
<TOKEN end_char="659" id="token-6-10" morph="none" pos="word" start_char="658">до</TOKEN>
<TOKEN end_char="667" id="token-6-11" morph="none" pos="word" start_char="661">тяжелой</TOKEN>
<TOKEN end_char="673" id="token-6-12" morph="none" pos="word" start_char="669">формы</TOKEN>
<TOKEN end_char="675" id="token-6-13" morph="none" pos="word" start_char="675">и</TOKEN>
<TOKEN end_char="690" id="token-6-14" morph="none" pos="word" start_char="677">госпитализации</TOKEN>
<TOKEN end_char="691" id="token-6-15" morph="none" pos="punct" start_char="691">.</TOKEN>
<TRANSLATED_TEXT>Sotrovimab will treat people at high risk of progression from COVID-19 to severe form and hospitalization.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="791" id="segment-7" start_char="694">
<ORIGINAL_TEXT>Препарат можно использовать пациентам и детям старше 12 лет, вес которых превышает 40 килограммов.</ORIGINAL_TEXT>
<TOKEN end_char="701" id="token-7-0" morph="none" pos="word" start_char="694">Препарат</TOKEN>
<TOKEN end_char="707" id="token-7-1" morph="none" pos="word" start_char="703">можно</TOKEN>
<TOKEN end_char="720" id="token-7-2" morph="none" pos="word" start_char="709">использовать</TOKEN>
<TOKEN end_char="730" id="token-7-3" morph="none" pos="word" start_char="722">пациентам</TOKEN>
<TOKEN end_char="732" id="token-7-4" morph="none" pos="word" start_char="732">и</TOKEN>
<TOKEN end_char="738" id="token-7-5" morph="none" pos="word" start_char="734">детям</TOKEN>
<TOKEN end_char="745" id="token-7-6" morph="none" pos="word" start_char="740">старше</TOKEN>
<TOKEN end_char="748" id="token-7-7" morph="none" pos="word" start_char="747">12</TOKEN>
<TOKEN end_char="752" id="token-7-8" morph="none" pos="word" start_char="750">лет</TOKEN>
<TOKEN end_char="753" id="token-7-9" morph="none" pos="punct" start_char="753">,</TOKEN>
<TOKEN end_char="757" id="token-7-10" morph="none" pos="word" start_char="755">вес</TOKEN>
<TOKEN end_char="765" id="token-7-11" morph="none" pos="word" start_char="759">которых</TOKEN>
<TOKEN end_char="775" id="token-7-12" morph="none" pos="word" start_char="767">превышает</TOKEN>
<TOKEN end_char="778" id="token-7-13" morph="none" pos="word" start_char="777">40</TOKEN>
<TOKEN end_char="790" id="token-7-14" morph="none" pos="word" start_char="780">килограммов</TOKEN>
<TOKEN end_char="791" id="token-7-15" morph="none" pos="punct" start_char="791">.</TOKEN>
<TRANSLATED_TEXT>It can be used in patients and children over 12 years of age who weigh more than 40 kilograms.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="824" id="segment-8" start_char="794">
<ORIGINAL_TEXT>Сотровимаб: что это за препарат</ORIGINAL_TEXT>
<TOKEN end_char="803" id="token-8-0" morph="none" pos="word" start_char="794">Сотровимаб</TOKEN>
<TOKEN end_char="804" id="token-8-1" morph="none" pos="punct" start_char="804">:</TOKEN>
<TOKEN end_char="808" id="token-8-2" morph="none" pos="word" start_char="806">что</TOKEN>
<TOKEN end_char="812" id="token-8-3" morph="none" pos="word" start_char="810">это</TOKEN>
<TOKEN end_char="815" id="token-8-4" morph="none" pos="word" start_char="814">за</TOKEN>
<TOKEN end_char="824" id="token-8-5" morph="none" pos="word" start_char="817">препарат</TOKEN>
<TRANSLATED_TEXT>Sotrovimab: What is this for?</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="1036" id="segment-9" start_char="828">
<ORIGINAL_TEXT>Это препарат, разработанный на основе моноклональных антител, которые специально нацелены на шиповой белок SARS-CoV-2 и предназначены для блокирования прикрепления вируса и его проникновение в клетки человека.</ORIGINAL_TEXT>
<TOKEN end_char="830" id="token-9-0" morph="none" pos="word" start_char="828">Это</TOKEN>
<TOKEN end_char="839" id="token-9-1" morph="none" pos="word" start_char="832">препарат</TOKEN>
<TOKEN end_char="840" id="token-9-2" morph="none" pos="punct" start_char="840">,</TOKEN>
<TOKEN end_char="854" id="token-9-3" morph="none" pos="word" start_char="842">разработанный</TOKEN>
<TOKEN end_char="857" id="token-9-4" morph="none" pos="word" start_char="856">на</TOKEN>
<TOKEN end_char="864" id="token-9-5" morph="none" pos="word" start_char="859">основе</TOKEN>
<TOKEN end_char="879" id="token-9-6" morph="none" pos="word" start_char="866">моноклональных</TOKEN>
<TOKEN end_char="887" id="token-9-7" morph="none" pos="word" start_char="881">антител</TOKEN>
<TOKEN end_char="888" id="token-9-8" morph="none" pos="punct" start_char="888">,</TOKEN>
<TOKEN end_char="896" id="token-9-9" morph="none" pos="word" start_char="890">которые</TOKEN>
<TOKEN end_char="907" id="token-9-10" morph="none" pos="word" start_char="898">специально</TOKEN>
<TOKEN end_char="916" id="token-9-11" morph="none" pos="word" start_char="909">нацелены</TOKEN>
<TOKEN end_char="919" id="token-9-12" morph="none" pos="word" start_char="918">на</TOKEN>
<TOKEN end_char="927" id="token-9-13" morph="none" pos="word" start_char="921">шиповой</TOKEN>
<TOKEN end_char="933" id="token-9-14" morph="none" pos="word" start_char="929">белок</TOKEN>
<TOKEN end_char="944" id="token-9-15" morph="none" pos="unknown" start_char="935">SARS-CoV-2</TOKEN>
<TOKEN end_char="946" id="token-9-16" morph="none" pos="word" start_char="946">и</TOKEN>
<TOKEN end_char="960" id="token-9-17" morph="none" pos="word" start_char="948">предназначены</TOKEN>
<TOKEN end_char="964" id="token-9-18" morph="none" pos="word" start_char="962">для</TOKEN>
<TOKEN end_char="977" id="token-9-19" morph="none" pos="word" start_char="966">блокирования</TOKEN>
<TOKEN end_char="990" id="token-9-20" morph="none" pos="word" start_char="979">прикрепления</TOKEN>
<TOKEN end_char="997" id="token-9-21" morph="none" pos="word" start_char="992">вируса</TOKEN>
<TOKEN end_char="999" id="token-9-22" morph="none" pos="word" start_char="999">и</TOKEN>
<TOKEN end_char="1003" id="token-9-23" morph="none" pos="word" start_char="1001">его</TOKEN>
<TOKEN end_char="1017" id="token-9-24" morph="none" pos="word" start_char="1005">проникновение</TOKEN>
<TOKEN end_char="1019" id="token-9-25" morph="none" pos="word" start_char="1019">в</TOKEN>
<TOKEN end_char="1026" id="token-9-26" morph="none" pos="word" start_char="1021">клетки</TOKEN>
<TOKEN end_char="1035" id="token-9-27" morph="none" pos="word" start_char="1028">человека</TOKEN>
<TOKEN end_char="1036" id="token-9-28" morph="none" pos="punct" start_char="1036">.</TOKEN>
<TRANSLATED_TEXT>It is a drug developed on the basis of monoclonal antibodies that specifically target the SARS-CoV-2 fungal protein and are designed to block the virus's attachment and penetration into human cells.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="1072" id="segment-10" start_char="1039">
<ORIGINAL_TEXT>Что такое моноклональные антитела?</ORIGINAL_TEXT>
<TOKEN end_char="1041" id="token-10-0" morph="none" pos="word" start_char="1039">Что</TOKEN>
<TOKEN end_char="1047" id="token-10-1" morph="none" pos="word" start_char="1043">такое</TOKEN>
<TOKEN end_char="1062" id="token-10-2" morph="none" pos="word" start_char="1049">моноклональные</TOKEN>
<TOKEN end_char="1071" id="token-10-3" morph="none" pos="word" start_char="1064">антитела</TOKEN>
<TOKEN end_char="1072" id="token-10-4" morph="none" pos="punct" start_char="1072">?</TOKEN>
<TRANSLATED_TEXT>What are monoclonal antibodies?</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="1208" id="segment-11" start_char="1076">
<ORIGINAL_TEXT>Это полученные в лаборатории белки, которые имитируют способность иммунной системы бороться с вредными антигенами, такими как вирусы.</ORIGINAL_TEXT>
<TOKEN end_char="1078" id="token-11-0" morph="none" pos="word" start_char="1076">Это</TOKEN>
<TOKEN end_char="1089" id="token-11-1" morph="none" pos="word" start_char="1080">полученные</TOKEN>
<TOKEN end_char="1091" id="token-11-2" morph="none" pos="word" start_char="1091">в</TOKEN>
<TOKEN end_char="1103" id="token-11-3" morph="none" pos="word" start_char="1093">лаборатории</TOKEN>
<TOKEN end_char="1109" id="token-11-4" morph="none" pos="word" start_char="1105">белки</TOKEN>
<TOKEN end_char="1110" id="token-11-5" morph="none" pos="punct" start_char="1110">,</TOKEN>
<TOKEN end_char="1118" id="token-11-6" morph="none" pos="word" start_char="1112">которые</TOKEN>
<TOKEN end_char="1128" id="token-11-7" morph="none" pos="word" start_char="1120">имитируют</TOKEN>
<TOKEN end_char="1140" id="token-11-8" morph="none" pos="word" start_char="1130">способность</TOKEN>
<TOKEN end_char="1149" id="token-11-9" morph="none" pos="word" start_char="1142">иммунной</TOKEN>
<TOKEN end_char="1157" id="token-11-10" morph="none" pos="word" start_char="1151">системы</TOKEN>
<TOKEN end_char="1166" id="token-11-11" morph="none" pos="word" start_char="1159">бороться</TOKEN>
<TOKEN end_char="1168" id="token-11-12" morph="none" pos="word" start_char="1168">с</TOKEN>
<TOKEN end_char="1177" id="token-11-13" morph="none" pos="word" start_char="1170">вредными</TOKEN>
<TOKEN end_char="1188" id="token-11-14" morph="none" pos="word" start_char="1179">антигенами</TOKEN>
<TOKEN end_char="1189" id="token-11-15" morph="none" pos="punct" start_char="1189">,</TOKEN>
<TOKEN end_char="1196" id="token-11-16" morph="none" pos="word" start_char="1191">такими</TOKEN>
<TOKEN end_char="1200" id="token-11-17" morph="none" pos="word" start_char="1198">как</TOKEN>
<TOKEN end_char="1207" id="token-11-18" morph="none" pos="word" start_char="1202">вирусы</TOKEN>
<TOKEN end_char="1208" id="token-11-19" morph="none" pos="punct" start_char="1208">.</TOKEN>
<TRANSLATED_TEXT>These are laboratory proteins that mimic the ability of the immune system to fight harmful antigens, such as viruses.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="1492" id="segment-12" start_char="1211">
<ORIGINAL_TEXT>Получив разрешение на лечение с помощью моноклональных антител, мы предоставляем еще один вариант, чтобы помочь пациентам с высоким риском COVID-19 не попадать в больницу, – заявила доктор медицины, директор Центра оценки и исследований лекарственных средств FDA Патриция Каваццони.</ORIGINAL_TEXT>
<TOKEN end_char="1217" id="token-12-0" morph="none" pos="word" start_char="1211">Получив</TOKEN>
<TOKEN end_char="1228" id="token-12-1" morph="none" pos="word" start_char="1219">разрешение</TOKEN>
<TOKEN end_char="1231" id="token-12-2" morph="none" pos="word" start_char="1230">на</TOKEN>
<TOKEN end_char="1239" id="token-12-3" morph="none" pos="word" start_char="1233">лечение</TOKEN>
<TOKEN end_char="1241" id="token-12-4" morph="none" pos="word" start_char="1241">с</TOKEN>
<TOKEN end_char="1249" id="token-12-5" morph="none" pos="word" start_char="1243">помощью</TOKEN>
<TOKEN end_char="1264" id="token-12-6" morph="none" pos="word" start_char="1251">моноклональных</TOKEN>
<TOKEN end_char="1272" id="token-12-7" morph="none" pos="word" start_char="1266">антител</TOKEN>
<TOKEN end_char="1273" id="token-12-8" morph="none" pos="punct" start_char="1273">,</TOKEN>
<TOKEN end_char="1276" id="token-12-9" morph="none" pos="word" start_char="1275">мы</TOKEN>
<TOKEN end_char="1290" id="token-12-10" morph="none" pos="word" start_char="1278">предоставляем</TOKEN>
<TOKEN end_char="1294" id="token-12-11" morph="none" pos="word" start_char="1292">еще</TOKEN>
<TOKEN end_char="1299" id="token-12-12" morph="none" pos="word" start_char="1296">один</TOKEN>
<TOKEN end_char="1307" id="token-12-13" morph="none" pos="word" start_char="1301">вариант</TOKEN>
<TOKEN end_char="1308" id="token-12-14" morph="none" pos="punct" start_char="1308">,</TOKEN>
<TOKEN end_char="1314" id="token-12-15" morph="none" pos="word" start_char="1310">чтобы</TOKEN>
<TOKEN end_char="1321" id="token-12-16" morph="none" pos="word" start_char="1316">помочь</TOKEN>
<TOKEN end_char="1331" id="token-12-17" morph="none" pos="word" start_char="1323">пациентам</TOKEN>
<TOKEN end_char="1333" id="token-12-18" morph="none" pos="word" start_char="1333">с</TOKEN>
<TOKEN end_char="1341" id="token-12-19" morph="none" pos="word" start_char="1335">высоким</TOKEN>
<TOKEN end_char="1348" id="token-12-20" morph="none" pos="word" start_char="1343">риском</TOKEN>
<TOKEN end_char="1357" id="token-12-21" morph="none" pos="unknown" start_char="1350">COVID-19</TOKEN>
<TOKEN end_char="1360" id="token-12-22" morph="none" pos="word" start_char="1359">не</TOKEN>
<TOKEN end_char="1369" id="token-12-23" morph="none" pos="word" start_char="1362">попадать</TOKEN>
<TOKEN end_char="1371" id="token-12-24" morph="none" pos="word" start_char="1371">в</TOKEN>
<TOKEN end_char="1380" id="token-12-25" morph="none" pos="word" start_char="1373">больницу</TOKEN>
<TOKEN end_char="1381" id="token-12-26" morph="none" pos="punct" start_char="1381">,</TOKEN>
<TOKEN end_char="1383" id="token-12-27" morph="none" pos="punct" start_char="1383">–</TOKEN>
<TOKEN end_char="1391" id="token-12-28" morph="none" pos="word" start_char="1385">заявила</TOKEN>
<TOKEN end_char="1398" id="token-12-29" morph="none" pos="word" start_char="1393">доктор</TOKEN>
<TOKEN end_char="1407" id="token-12-30" morph="none" pos="word" start_char="1400">медицины</TOKEN>
<TOKEN end_char="1408" id="token-12-31" morph="none" pos="punct" start_char="1408">,</TOKEN>
<TOKEN end_char="1417" id="token-12-32" morph="none" pos="word" start_char="1410">директор</TOKEN>
<TOKEN end_char="1424" id="token-12-33" morph="none" pos="word" start_char="1419">Центра</TOKEN>
<TOKEN end_char="1431" id="token-12-34" morph="none" pos="word" start_char="1426">оценки</TOKEN>
<TOKEN end_char="1433" id="token-12-35" morph="none" pos="word" start_char="1433">и</TOKEN>
<TOKEN end_char="1446" id="token-12-36" morph="none" pos="word" start_char="1435">исследований</TOKEN>
<TOKEN end_char="1460" id="token-12-37" morph="none" pos="word" start_char="1448">лекарственных</TOKEN>
<TOKEN end_char="1468" id="token-12-38" morph="none" pos="word" start_char="1462">средств</TOKEN>
<TOKEN end_char="1472" id="token-12-39" morph="none" pos="word" start_char="1470">FDA</TOKEN>
<TOKEN end_char="1481" id="token-12-40" morph="none" pos="word" start_char="1474">Патриция</TOKEN>
<TOKEN end_char="1491" id="token-12-41" morph="none" pos="word" start_char="1483">Каваццони</TOKEN>
<TOKEN end_char="1492" id="token-12-42" morph="none" pos="punct" start_char="1492">.</TOKEN>
<TRANSLATED_TEXT>Having received permission to treat with monoclonal antibodies, we offer another option to help patients at high risk of COVID-19 not to get to hospital, "said Dr. Patricia Kavatsoni, Director of the FDA Drug Evaluation and Research Center.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="1530" id="segment-13" start_char="1495">
<ORIGINAL_TEXT>Результаты исследований Сотровимаба:</ORIGINAL_TEXT>
<TOKEN end_char="1504" id="token-13-0" morph="none" pos="word" start_char="1495">Результаты</TOKEN>
<TOKEN end_char="1517" id="token-13-1" morph="none" pos="word" start_char="1506">исследований</TOKEN>
<TOKEN end_char="1529" id="token-13-2" morph="none" pos="word" start_char="1519">Сотровимаба</TOKEN>
<TOKEN end_char="1530" id="token-13-3" morph="none" pos="punct" start_char="1530">:</TOKEN>
<TRANSLATED_TEXT>Results of Sotrovimab studies:</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="1652" id="segment-14" start_char="1535">
<ORIGINAL_TEXT>Прежде чем препарат одобрили, он прошел двойные слепые плацебо-контролируемые клинические исследования 1, 2, и 3 фазы.</ORIGINAL_TEXT>
<TOKEN end_char="1540" id="token-14-0" morph="none" pos="word" start_char="1535">Прежде</TOKEN>
<TOKEN end_char="1544" id="token-14-1" morph="none" pos="word" start_char="1542">чем</TOKEN>
<TOKEN end_char="1553" id="token-14-2" morph="none" pos="word" start_char="1546">препарат</TOKEN>
<TOKEN end_char="1562" id="token-14-3" morph="none" pos="word" start_char="1555">одобрили</TOKEN>
<TOKEN end_char="1563" id="token-14-4" morph="none" pos="punct" start_char="1563">,</TOKEN>
<TOKEN end_char="1566" id="token-14-5" morph="none" pos="word" start_char="1565">он</TOKEN>
<TOKEN end_char="1573" id="token-14-6" morph="none" pos="word" start_char="1568">прошел</TOKEN>
<TOKEN end_char="1581" id="token-14-7" morph="none" pos="word" start_char="1575">двойные</TOKEN>
<TOKEN end_char="1588" id="token-14-8" morph="none" pos="word" start_char="1583">слепые</TOKEN>
<TOKEN end_char="1611" id="token-14-9" morph="none" pos="unknown" start_char="1590">плацебо-контролируемые</TOKEN>
<TOKEN end_char="1623" id="token-14-10" morph="none" pos="word" start_char="1613">клинические</TOKEN>
<TOKEN end_char="1636" id="token-14-11" morph="none" pos="word" start_char="1625">исследования</TOKEN>
<TOKEN end_char="1638" id="token-14-12" morph="none" pos="word" start_char="1638">1</TOKEN>
<TOKEN end_char="1639" id="token-14-13" morph="none" pos="punct" start_char="1639">,</TOKEN>
<TOKEN end_char="1641" id="token-14-14" morph="none" pos="word" start_char="1641">2</TOKEN>
<TOKEN end_char="1642" id="token-14-15" morph="none" pos="punct" start_char="1642">,</TOKEN>
<TOKEN end_char="1644" id="token-14-16" morph="none" pos="word" start_char="1644">и</TOKEN>
<TOKEN end_char="1646" id="token-14-17" morph="none" pos="word" start_char="1646">3</TOKEN>
<TOKEN end_char="1651" id="token-14-18" morph="none" pos="word" start_char="1648">фазы</TOKEN>
<TOKEN end_char="1652" id="token-14-19" morph="none" pos="punct" start_char="1652">.</TOKEN>
<TRANSLATED_TEXT>Before the drug was approved, he underwent double blind placebo-controlled clinical trials of phases 1, 2, and 3.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="1827" id="segment-15" start_char="1656">
<ORIGINAL_TEXT>В испытаниях приняли участие 583 не госпитализированных взрослых с легкими или умеренными симптомами COVID-19, которые получили положительный результат теста на SARS-CoV-2.</ORIGINAL_TEXT>
<TOKEN end_char="1656" id="token-15-0" morph="none" pos="word" start_char="1656">В</TOKEN>
<TOKEN end_char="1667" id="token-15-1" morph="none" pos="word" start_char="1658">испытаниях</TOKEN>
<TOKEN end_char="1675" id="token-15-2" morph="none" pos="word" start_char="1669">приняли</TOKEN>
<TOKEN end_char="1683" id="token-15-3" morph="none" pos="word" start_char="1677">участие</TOKEN>
<TOKEN end_char="1687" id="token-15-4" morph="none" pos="word" start_char="1685">583</TOKEN>
<TOKEN end_char="1690" id="token-15-5" morph="none" pos="word" start_char="1689">не</TOKEN>
<TOKEN end_char="1710" id="token-15-6" morph="none" pos="word" start_char="1692">госпитализированных</TOKEN>
<TOKEN end_char="1719" id="token-15-7" morph="none" pos="word" start_char="1712">взрослых</TOKEN>
<TOKEN end_char="1721" id="token-15-8" morph="none" pos="word" start_char="1721">с</TOKEN>
<TOKEN end_char="1729" id="token-15-9" morph="none" pos="word" start_char="1723">легкими</TOKEN>
<TOKEN end_char="1733" id="token-15-10" morph="none" pos="word" start_char="1731">или</TOKEN>
<TOKEN end_char="1744" id="token-15-11" morph="none" pos="word" start_char="1735">умеренными</TOKEN>
<TOKEN end_char="1755" id="token-15-12" morph="none" pos="word" start_char="1746">симптомами</TOKEN>
<TOKEN end_char="1764" id="token-15-13" morph="none" pos="unknown" start_char="1757">COVID-19</TOKEN>
<TOKEN end_char="1765" id="token-15-14" morph="none" pos="punct" start_char="1765">,</TOKEN>
<TOKEN end_char="1773" id="token-15-15" morph="none" pos="word" start_char="1767">которые</TOKEN>
<TOKEN end_char="1782" id="token-15-16" morph="none" pos="word" start_char="1775">получили</TOKEN>
<TOKEN end_char="1796" id="token-15-17" morph="none" pos="word" start_char="1784">положительный</TOKEN>
<TOKEN end_char="1806" id="token-15-18" morph="none" pos="word" start_char="1798">результат</TOKEN>
<TOKEN end_char="1812" id="token-15-19" morph="none" pos="word" start_char="1808">теста</TOKEN>
<TOKEN end_char="1815" id="token-15-20" morph="none" pos="word" start_char="1814">на</TOKEN>
<TOKEN end_char="1826" id="token-15-21" morph="none" pos="unknown" start_char="1817">SARS-CoV-2</TOKEN>
<TOKEN end_char="1827" id="token-15-22" morph="none" pos="punct" start_char="1827">.</TOKEN>
<TRANSLATED_TEXT>583 adults with mild or moderate COVID-19 symptoms who tested positive for SARS-CoV-2 were not hospitalized.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="1946" id="segment-16" start_char="1831">
<ORIGINAL_TEXT>В течение 5 дней после появления симптомов 291 из этих пациентов получал настоящий препарат, а 292 получали плацебо.</ORIGINAL_TEXT>
<TOKEN end_char="1831" id="token-16-0" morph="none" pos="word" start_char="1831">В</TOKEN>
<TOKEN end_char="1839" id="token-16-1" morph="none" pos="word" start_char="1833">течение</TOKEN>
<TOKEN end_char="1841" id="token-16-2" morph="none" pos="word" start_char="1841">5</TOKEN>
<TOKEN end_char="1846" id="token-16-3" morph="none" pos="word" start_char="1843">дней</TOKEN>
<TOKEN end_char="1852" id="token-16-4" morph="none" pos="word" start_char="1848">после</TOKEN>
<TOKEN end_char="1862" id="token-16-5" morph="none" pos="word" start_char="1854">появления</TOKEN>
<TOKEN end_char="1872" id="token-16-6" morph="none" pos="word" start_char="1864">симптомов</TOKEN>
<TOKEN end_char="1876" id="token-16-7" morph="none" pos="word" start_char="1874">291</TOKEN>
<TOKEN end_char="1879" id="token-16-8" morph="none" pos="word" start_char="1878">из</TOKEN>
<TOKEN end_char="1884" id="token-16-9" morph="none" pos="word" start_char="1881">этих</TOKEN>
<TOKEN end_char="1894" id="token-16-10" morph="none" pos="word" start_char="1886">пациентов</TOKEN>
<TOKEN end_char="1902" id="token-16-11" morph="none" pos="word" start_char="1896">получал</TOKEN>
<TOKEN end_char="1912" id="token-16-12" morph="none" pos="word" start_char="1904">настоящий</TOKEN>
<TOKEN end_char="1921" id="token-16-13" morph="none" pos="word" start_char="1914">препарат</TOKEN>
<TOKEN end_char="1922" id="token-16-14" morph="none" pos="punct" start_char="1922">,</TOKEN>
<TOKEN end_char="1924" id="token-16-15" morph="none" pos="word" start_char="1924">а</TOKEN>
<TOKEN end_char="1928" id="token-16-16" morph="none" pos="word" start_char="1926">292</TOKEN>
<TOKEN end_char="1937" id="token-16-17" morph="none" pos="word" start_char="1930">получали</TOKEN>
<TOKEN end_char="1945" id="token-16-18" morph="none" pos="word" start_char="1939">плацебо</TOKEN>
<TOKEN end_char="1946" id="token-16-19" morph="none" pos="punct" start_char="1946">.</TOKEN>
<TRANSLATED_TEXT>Within five days of the onset of symptoms, 291 of these patients received the real drug and 292 received placebo.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="2036" id="segment-17" start_char="1950">
<ORIGINAL_TEXT>Среди людей, которые получали Сотровимаб, госпитализировали или умерли 3 пациента (1%).</ORIGINAL_TEXT>
<TOKEN end_char="1954" id="token-17-0" morph="none" pos="word" start_char="1950">Среди</TOKEN>
<TOKEN end_char="1960" id="token-17-1" morph="none" pos="word" start_char="1956">людей</TOKEN>
<TOKEN end_char="1961" id="token-17-2" morph="none" pos="punct" start_char="1961">,</TOKEN>
<TOKEN end_char="1969" id="token-17-3" morph="none" pos="word" start_char="1963">которые</TOKEN>
<TOKEN end_char="1978" id="token-17-4" morph="none" pos="word" start_char="1971">получали</TOKEN>
<TOKEN end_char="1989" id="token-17-5" morph="none" pos="word" start_char="1980">Сотровимаб</TOKEN>
<TOKEN end_char="1990" id="token-17-6" morph="none" pos="punct" start_char="1990">,</TOKEN>
<TOKEN end_char="2008" id="token-17-7" morph="none" pos="word" start_char="1992">госпитализировали</TOKEN>
<TOKEN end_char="2012" id="token-17-8" morph="none" pos="word" start_char="2010">или</TOKEN>
<TOKEN end_char="2019" id="token-17-9" morph="none" pos="word" start_char="2014">умерли</TOKEN>
<TOKEN end_char="2021" id="token-17-10" morph="none" pos="word" start_char="2021">3</TOKEN>
<TOKEN end_char="2030" id="token-17-11" morph="none" pos="word" start_char="2023">пациента</TOKEN>
<TOKEN end_char="2032" id="token-17-12" morph="none" pos="punct" start_char="2032">(</TOKEN>
<TOKEN end_char="2033" id="token-17-13" morph="none" pos="word" start_char="2033">1</TOKEN>
<TOKEN end_char="2036" id="token-17-14" morph="none" pos="punct" start_char="2034">%).</TOKEN>
<TRANSLATED_TEXT>Of those receiving Sotrovimab, 3 patients (1%) were hospitalized or died.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="2146" id="segment-18" start_char="2038">
<ORIGINAL_TEXT>Зато среди людей, которые употребляли ненастоящий препарат, смерть или госпитализация ждали 21 (7%) пациента.</ORIGINAL_TEXT>
<TOKEN end_char="2041" id="token-18-0" morph="none" pos="word" start_char="2038">Зато</TOKEN>
<TOKEN end_char="2047" id="token-18-1" morph="none" pos="word" start_char="2043">среди</TOKEN>
<TOKEN end_char="2053" id="token-18-2" morph="none" pos="word" start_char="2049">людей</TOKEN>
<TOKEN end_char="2054" id="token-18-3" morph="none" pos="punct" start_char="2054">,</TOKEN>
<TOKEN end_char="2062" id="token-18-4" morph="none" pos="word" start_char="2056">которые</TOKEN>
<TOKEN end_char="2074" id="token-18-5" morph="none" pos="word" start_char="2064">употребляли</TOKEN>
<TOKEN end_char="2086" id="token-18-6" morph="none" pos="word" start_char="2076">ненастоящий</TOKEN>
<TOKEN end_char="2095" id="token-18-7" morph="none" pos="word" start_char="2088">препарат</TOKEN>
<TOKEN end_char="2096" id="token-18-8" morph="none" pos="punct" start_char="2096">,</TOKEN>
<TOKEN end_char="2103" id="token-18-9" morph="none" pos="word" start_char="2098">смерть</TOKEN>
<TOKEN end_char="2107" id="token-18-10" morph="none" pos="word" start_char="2105">или</TOKEN>
<TOKEN end_char="2122" id="token-18-11" morph="none" pos="word" start_char="2109">госпитализация</TOKEN>
<TOKEN end_char="2128" id="token-18-12" morph="none" pos="word" start_char="2124">ждали</TOKEN>
<TOKEN end_char="2131" id="token-18-13" morph="none" pos="word" start_char="2130">21</TOKEN>
<TOKEN end_char="2133" id="token-18-14" morph="none" pos="punct" start_char="2133">(</TOKEN>
<TOKEN end_char="2134" id="token-18-15" morph="none" pos="word" start_char="2134">7</TOKEN>
<TOKEN end_char="2136" id="token-18-16" morph="none" pos="punct" start_char="2135">%)</TOKEN>
<TOKEN end_char="2145" id="token-18-17" morph="none" pos="word" start_char="2138">пациента</TOKEN>
<TOKEN end_char="2146" id="token-18-18" morph="none" pos="punct" start_char="2146">.</TOKEN>
<TRANSLATED_TEXT>In contrast, 21 (7%) of people who had taken the drug were waiting for death or hospitalization.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="2209" id="segment-19" start_char="2151">
<ORIGINAL_TEXT>Инструкция по применению препарата в США и побочные эффекты</ORIGINAL_TEXT>
<TOKEN end_char="2160" id="token-19-0" morph="none" pos="word" start_char="2151">Инструкция</TOKEN>
<TOKEN end_char="2163" id="token-19-1" morph="none" pos="word" start_char="2162">по</TOKEN>
<TOKEN end_char="2174" id="token-19-2" morph="none" pos="word" start_char="2165">применению</TOKEN>
<TOKEN end_char="2184" id="token-19-3" morph="none" pos="word" start_char="2176">препарата</TOKEN>
<TOKEN end_char="2186" id="token-19-4" morph="none" pos="word" start_char="2186">в</TOKEN>
<TOKEN end_char="2190" id="token-19-5" morph="none" pos="word" start_char="2188">США</TOKEN>
<TOKEN end_char="2192" id="token-19-6" morph="none" pos="word" start_char="2192">и</TOKEN>
<TOKEN end_char="2201" id="token-19-7" morph="none" pos="word" start_char="2194">побочные</TOKEN>
<TOKEN end_char="2209" id="token-19-8" morph="none" pos="word" start_char="2203">эффекты</TOKEN>
<TRANSLATED_TEXT>U.S. Drug Enforcement Administration (DEA) and.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="2331" id="segment-20" start_char="2213">
<ORIGINAL_TEXT>Поставщикам медицинских услуг разрешили распространять и вводить Сотровимаб в виде однократной дозы 500 мг внутривенно.</ORIGINAL_TEXT>
<TOKEN end_char="2223" id="token-20-0" morph="none" pos="word" start_char="2213">Поставщикам</TOKEN>
<TOKEN end_char="2235" id="token-20-1" morph="none" pos="word" start_char="2225">медицинских</TOKEN>
<TOKEN end_char="2241" id="token-20-2" morph="none" pos="word" start_char="2237">услуг</TOKEN>
<TOKEN end_char="2251" id="token-20-3" morph="none" pos="word" start_char="2243">разрешили</TOKEN>
<TOKEN end_char="2266" id="token-20-4" morph="none" pos="word" start_char="2253">распространять</TOKEN>
<TOKEN end_char="2268" id="token-20-5" morph="none" pos="word" start_char="2268">и</TOKEN>
<TOKEN end_char="2276" id="token-20-6" morph="none" pos="word" start_char="2270">вводить</TOKEN>
<TOKEN end_char="2287" id="token-20-7" morph="none" pos="word" start_char="2278">Сотровимаб</TOKEN>
<TOKEN end_char="2289" id="token-20-8" morph="none" pos="word" start_char="2289">в</TOKEN>
<TOKEN end_char="2294" id="token-20-9" morph="none" pos="word" start_char="2291">виде</TOKEN>
<TOKEN end_char="2306" id="token-20-10" morph="none" pos="word" start_char="2296">однократной</TOKEN>
<TOKEN end_char="2311" id="token-20-11" morph="none" pos="word" start_char="2308">дозы</TOKEN>
<TOKEN end_char="2315" id="token-20-12" morph="none" pos="word" start_char="2313">500</TOKEN>
<TOKEN end_char="2318" id="token-20-13" morph="none" pos="word" start_char="2317">мг</TOKEN>
<TOKEN end_char="2330" id="token-20-14" morph="none" pos="word" start_char="2320">внутривенно</TOKEN>
<TOKEN end_char="2331" id="token-20-15" morph="none" pos="punct" start_char="2331">.</TOKEN>
<TRANSLATED_TEXT>Health providers were allowed to distribute and administer Sotrovimab as a single dose of 500 mg intravenously.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="2437" id="segment-21" start_char="2334">
<ORIGINAL_TEXT>Возможные побочные эффекты препарата включают анафилаксию, сыпь, диарею и реакции, связанные с инфузией.</ORIGINAL_TEXT>
<TOKEN end_char="2342" id="token-21-0" morph="none" pos="word" start_char="2334">Возможные</TOKEN>
<TOKEN end_char="2351" id="token-21-1" morph="none" pos="word" start_char="2344">побочные</TOKEN>
<TOKEN end_char="2359" id="token-21-2" morph="none" pos="word" start_char="2353">эффекты</TOKEN>
<TOKEN end_char="2369" id="token-21-3" morph="none" pos="word" start_char="2361">препарата</TOKEN>
<TOKEN end_char="2378" id="token-21-4" morph="none" pos="word" start_char="2371">включают</TOKEN>
<TOKEN end_char="2390" id="token-21-5" morph="none" pos="word" start_char="2380">анафилаксию</TOKEN>
<TOKEN end_char="2391" id="token-21-6" morph="none" pos="punct" start_char="2391">,</TOKEN>
<TOKEN end_char="2396" id="token-21-7" morph="none" pos="word" start_char="2393">сыпь</TOKEN>
<TOKEN end_char="2397" id="token-21-8" morph="none" pos="punct" start_char="2397">,</TOKEN>
<TOKEN end_char="2404" id="token-21-9" morph="none" pos="word" start_char="2399">диарею</TOKEN>
<TOKEN end_char="2406" id="token-21-10" morph="none" pos="word" start_char="2406">и</TOKEN>
<TOKEN end_char="2414" id="token-21-11" morph="none" pos="word" start_char="2408">реакции</TOKEN>
<TOKEN end_char="2415" id="token-21-12" morph="none" pos="punct" start_char="2415">,</TOKEN>
<TOKEN end_char="2425" id="token-21-13" morph="none" pos="word" start_char="2417">связанные</TOKEN>
<TOKEN end_char="2427" id="token-21-14" morph="none" pos="word" start_char="2427">с</TOKEN>
<TOKEN end_char="2436" id="token-21-15" morph="none" pos="word" start_char="2429">инфузией</TOKEN>
<TOKEN end_char="2437" id="token-21-16" morph="none" pos="punct" start_char="2437">.</TOKEN>
<TRANSLATED_TEXT>Possible side effects include anaphylaxis, rash, diarrhoea, and reactions associated with infusion.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="2465" id="segment-22" start_char="2440">
<ORIGINAL_TEXT>Источник: healthy.24tv.ua/</ORIGINAL_TEXT>
<TOKEN end_char="2447" id="token-22-0" morph="none" pos="word" start_char="2440">Источник</TOKEN>
<TOKEN end_char="2448" id="token-22-1" morph="none" pos="punct" start_char="2448">:</TOKEN>
<TOKEN end_char="2464" id="token-22-2" morph="none" pos="unknown" start_char="2450">healthy.24tv.ua</TOKEN>
<TOKEN end_char="2465" id="token-22-3" morph="none" pos="punct" start_char="2465">/</TOKEN>
<TRANSLATED_TEXT>Source: healthy.24tv.ua /</TRANSLATED_TEXT><DETECTED_LANGUAGE>mk</DETECTED_LANGUAGE></SEG>
<SEG end_char="2497" id="segment-23" start_char="2468">
<ORIGINAL_TEXT>Новости портала «Весь Харьков»</ORIGINAL_TEXT>
<TOKEN end_char="2474" id="token-23-0" morph="none" pos="word" start_char="2468">Новости</TOKEN>
<TOKEN end_char="2482" id="token-23-1" morph="none" pos="word" start_char="2476">портала</TOKEN>
<TOKEN end_char="2484" id="token-23-2" morph="none" pos="punct" start_char="2484">«</TOKEN>
<TOKEN end_char="2488" id="token-23-3" morph="none" pos="word" start_char="2485">Весь</TOKEN>
<TOKEN end_char="2496" id="token-23-4" morph="none" pos="word" start_char="2490">Харьков</TOKEN>
<TOKEN end_char="2497" id="token-23-5" morph="none" pos="punct" start_char="2497">»</TOKEN>
<TRANSLATED_TEXT>All Kharkov portal news</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
</TEXT>
</DOC>
</LCTL_TEXT>